XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
MetaMask Security Incident: Validator Exits Begin
MetaMask confirmed on September 30, 2026 that it is responding to an ongoing security incident affecting part of its infrastructure, and said it has begun proac...
US Judge Rejects Claims Over 127,271 BTC Forfeiture
A US federal judge has rejected claims challenging the forfeiture of roughly 127,271 BTC, clearing a major procedural hurdle for the government’s effort to asse...
Anthropic Pre-IPO Perpetuals Reach $643M Across 12 Venues: Binance Research
Anthropic pre-IPO perpetuals recorded US$643 million in trading volume across 12 crypto venues in September month-to-date, surpassing the US$590M logged across...
SEC Chair Paul Atkins Says Agency Is Working on Crypto Regulatory Clarity
Atkins stated at the America First Policy Institute that the SEC is working to give crypto participants clearer regulatory expectations. His remarks framed the...
Aave’s $50M Institutional Lending Facility: How Losses Could Occur Without Default
A proposal circulating in Aave governance would establish a $50 million institutional lending facility, but the structure raises an unusual risk: the facility c...
Robinhood to Launch Crypto Perpetual Futures in the US
The announcement positions Robinhood as one of the few retail-facing US platforms preparing to offer perpetual futures domestically. Access will be limited to e...
